possible to investigate the longitudinal implications and the potential causes and clinical significance of these lesions. A recent cross-sectional study in a memory-clinic population detected CMIs on 3.0T MRI and observed a strong association between CMIs and large infarcts. 6 Here, we studied CMIs in the context of stroke, aiming to investigate the frequency, risk factors, and cognitive consequences of CMIs in patients with acute ischemic stroke/transient ischemic attack (TIA), using 3.0T MRI.
Methods Subjects
Subjects were participants of the ongoing STRIDE study (Stroke Registry Investigating Cognitive Decline). 7 The STRIDE study recruited 1062 consecutive patients with acute ischemic stroke/TIA admitted to the Prince of Wales Hospital in Hong Kong between 2009 and 2010, aiming to investigate mechanisms of cognitive trajectory over a 5-year period. MRI was performed within 1 week of hospital admission. Patients with known Alzheimer's disease or other nonvascular causes of dementia were excluded. Noncontrast brain computed tomography was performed for all patients on arrival to the hospital. We performed brain MRI on patients within 1 week of hospital admission on patients whom we were unable to classify the stroke subtype based on computed tomography and other clinical parameters. A total of 247 patients who underwent 3.0T MRI scanning at baseline in the STRIDE study were screened for inclusion in this study. Sixteen patients were excluded because of poor imaging quality, leaving 231 patients in this study. The excluded patients (n=831) were older (70.4 versus 66.9 years; P<0.001), less educated (5.4 versus 6.3 years; P=0.017), more cognitively impaired (Montreal Cognitive Assessment [MoCA] total score, 19.6 versus 21.1 points; P=0.002), and had more often atrial fibrillation (AF; 19.3% versus 6.5%; P<0.001), compared with patients who met the inclusion criteria for the present 3.0T MRI study (n=231). This study was approved by the Joint Chinese University of Hong KongNew Territories East Cluster Clinical Research Ethics committee, and written informed consent was obtained from each participant.
Demographic and Vascular Risk Factors
Basic demographic (age, sex, and years of education) and vascular risk factors at 3 to 6 months after stroke/TIA were collected. Hypertension was defined as systolic blood pressure >140 mm Hg and/or diastolic blood pressure >90 mm Hg, a history of hypertension or the use of antihypertensive medication. Diabetes mellitus was defined as fasting serum glucose ≥7.0 mmol/L, postprandial serum glucose ≥11.1 mmol/L, or the use of hypoglycemic agents or insulin. Hyperlipidemia was defined as total cholesterol level of ≥5.2 mmol/L, low-density lipoprotein cholesterol level of ≥2.6 mmol/L, triglyceride level of ≥1.70 mmol/L, or use of lipid-lowering drugs. Smoking/alcohol intake was dichotomized as ever or never smoked and ever or never used alcohol regularly, respectively. AF was diagnosed on the results of at least 1 ECG obtained before or during hospitalization. In cases with large cortical/subcortical stroke and normal ECG at admission, if further vascular work-up (eg, transcranial Doppler ultrasound, MR angiography) failed to detect relevant large-artery diseases, continuous inpatient monitoring and/or 24-hour Holter monitoring were arranged to look for paroxysmal AF. History of stroke/TIA was also recorded. Stroke subtype was categorized using the TOAST criteria (Trial of Org 10172 in Acute Stroke Treatment). Ischemic stroke was classified into large-artery atherosclerosis, small-artery occlusion, cardioembolism, stroke of other determined cause, and stroke of undetermined cause. 8 
Neuropsychological Assessment
Cognitive functions were assessed using the Hong Kong version of the MoCA 9 at 3 to 6 and 28 months after stroke and TIA, respectively. Our assessment time frame of 3 to 6 months is based on the conventional practice of previous studies on early poststroke dementia. 10 The MoCA total score was used to index global cognitive functions. According to predefined criteria, MoCA subscores were divided into 5 cognitive domains: memory, visuospatial, language, attention, and executive functions. 11 The 4, 10 we defined a cortical CMI on 3.0T MRI as hyperintense on FLAIR, hyperintense on T2-weighted, and hypointense on T1-weighted scans. Each lesion had to be detectable on all these 3 sequences (T1, T2, and FLAIR), restricted to the cortex and <5 mm in diameter. The diameter of cortical CMIs was measured on the FLAIR sequence, in the greatest dimension. DWI was used to check whether these lesions were acute (hyperintense on DWI) or chronic (isointense on DWI). CMIs were counted by a neurologist (Z.W.) trained by S. van Veluw, and uncertain cases were verified by S. van Veluw, who is experienced in rating CMIs on both 7.0T and 3.0T MRI. 3, 4, 6 The intrarater agreement was good for rating CMIs on 30 randomly selected patients (intraclass correlation coefficient, 0.83). Severity of white matter hyperintensities (WMH) was rated on axial FLAIR using the Age-Related White Matter Changes Scale.
14 Because pathological studies show that early confluent to confluent lesions are likely to represent true ischemic lesions associated with cerebral small vessel disease, whereas punctate lesions are commonly nonischemic, 15 severity of WMH was dichotomized into 2 levels: nonconfluent WMH and confluent WMH, which was defined as a score of ≥2 based on the Age-Related White Matter Changes Scale in at least 1 brain region. The ventricular-brain ratio, a marker of brain atrophy, was calculated as the mean of the biventricular width at the level of the frontal and occipital horns and at the level of the body of the caudate nuclei divided by the corresponding brain width at those levels on MRI. 16 Medial temporal lobe atrophy was rated on the T1-weighted coronal sequence using the Scheltens 5-point (0-4) scale, and medial temporal lobe atrophy was defined as ratings ≥2. 17 The number of lacunes, defined as hypointense lesions ≤15 mm on T1, and hypointense with a hyperintense rim on FLAIR, was also recorded. Cerebral microbleeds, defined as focal areas of low signal intensity of ≤10 mm, were counted on susceptibility-weighted imaging. 18 Infarcts were manually segmented on the DWI sequence by a technical expert with relevant clinical background. 19 All ratings were performed blind to patients' clinical data.
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Statistics
Comparisons between patients with and without cortical CMIs were performed using Pearson χ 2 test, Fisher exact test, independent samples t test or Mann-Whitney U test, as appropriate. To explore risk factors of cortical CMIs, factors with a P<0.1 in univariable analysis were entered into multivariable logistic regression models. To examine the cross-sectional association between CMI and cognition, MoCA total and domain scores were compared between patients with and without CMI, adjusting for age, sex, and education by ANCOVA. Linear regression was used to investigate the associations between the presence of cortical CMIs at baseline with longitudinal changes in cognitive scores with adjustment for age, sex, education, medial temporal lobe atrophy (yes versus no), ventricular-brain ratio, WMH (confluent versus nonconfluent), lacunes (≥1 versus none), and cerebral microbleeds (≥1 versus none). Normality of the regression residuals was checked using histogram and normal probability plots of residuals. SPSS 16.0 was used and α was set at 0.05 for all statistical analyses.
Results
Among 231 patients who underwent 3.0T MRI, 42 cortical CMIs were detected in 34 patients (14.7%). Twenty-nine patients had 1 CMI, 3 patients had 2 CMIs, 1 patient had 3 CMIs, and 1 patient had 4 CMIs. Twenty subjects harbored 22 CMIs in the left hemisphere, whereas 14 subjects had 20 CMIs in the right hemisphere. Among these 42 cortical CMIs, the vast majority of CMIs was located in frontal (n=19) and parietal (n=19) areas. The diameter of CMIs ranged from 1 to 3 mm. Evaluation of DWI scans revealed that 15 CMIs in 13 patients were acute (Figure) , whereas the other 27 CMIs in 21 patients were chronic.
Comparisons of baseline characteristics between patients with cortical (including both chronic and acute, n=34) CMIs and patients without CMIs (n=197) are shown in Table 1 . The presence of cortical CMIs was related to AF (P=0.012), history of previous stroke/TIA (P=0.054), or TOAST classification (P=0.004). The association of CMIs with TOAST classification was largely related to presence of cardioembolism (20.6% versus 4.6%; Table 1 ). In addition, men tended to have more cortical CMIs than women (P=0.097). No other difference was observed between patients with and without CMIs.
In multivariable regression models ( Table 2 ).
At baseline, MoCA assessment was available in 219 patients. Compared with patients without CMI, patients with CMI scored lower in the MoCA visuospatial domain score. There was no group difference in other domain scores or total score on the MoCA (Table 3) . Because of dropout and death, MoCA assessment was available in 154 (70.3%) subjects at 28-month follow-up. Among these 154 subjects, 27 subjects had CMIs, with 16 subjects harboring CMIs in the left hemisphere and 11 subjects in the right hemisphere. No baseline difference in demographic, clinical, and imaging characteristics was found between subjects with (n=154) and without (n=65) follow-up assessments (Table I in the online-only Data Supplement). The association of all baseline CMIs with cognitive decline over 28-month follow-up is shown in Table 4 . The presence of cortical CMIs at baseline was significantly associated with decline in visuospatial domain score only (β=0.5; 95% CI, 0.1-1.0; P=0.008 after adjusting for age, sex, education, baseline cognitive function, WMH, lacunes, medial temporal lobe atrophy, ventricular-brain ratio, and microbleeds). Further adjustments of recurrent stroke and volume of acute infarct of initial stroke did not change this association (β=0.5; 95% CI, 0.02-1.0; P=0.043). Decline in visuospatial functions was not associated with laterality of CMIs (data not shown).
Discussion
Cortical CMIs on 3.0T MRI were observed in 1 of 7 patients with ischemic stroke/TIA. Cortical CMIs were associated with AF and confluent WMH, suggesting that CMIs in patients with stroke may have a heterogeneous cause, involving microembolism and small vessel disease. Moreover, the presence of cortical CMIs at baseline was associated with poor visuospatial functioning at baseline and predicted its decline over 28 months.
CMIs have recently attracted increasing attention particularly in the field of vascular cognitive impairment. Pathological studies mainly focusing on patients with dementia or healthy subjects reported a high prevalence of CMIs. 1, 20, 21 To date, CMIs have not been assessed in vivo in stroke populations, which are likely to have a higher vascular risk burden than in patients presenting to memory clinics. Recently, it was shown that cortical CMIs can be visualized with not only 7.0T MRI but also 3.0T MRI, 4, 22 making it possible to study the clinical significance and longitudinal consequences of these lesions in living patients. It should be noted that 3.0T MRI has lower sensitivity but similar specificity than 7.0T MRI for the detection of CMIs. 6 The diameter of CMIs detected in our study was ≥ 1 mm, indicating that only the larger CMIs can be detected on 3.0T MRI. 3, 5, 23 Hence, the actual burden of CMIs in patients with stroke/ TIA is likely to be much greater than what can be appreciated on MRI.
The cause of CMIs is still largely unknown, but likely to be multifactorial. It is thus important to establish risk factors of CMIs, shedding light on relevant pathophysiologic pathways. The association of AF with CMIs suggests microembolism as a possible pathogenesis of CMIs. 24 Several studies showed an association of AF with cognitive impairment, 25 which may be partly mediated by AF-related cortical CMIs, based on the findings of our study. WMH is considered a conventional marker of SVD representing heterogeneous smallvessel pathologies, including hypertensive arteriopathy and hypoperfusion. Hence, these causes may also contribute to the development of CMIs. One study found that CMIs in Alzheimer's disease were preferentially distributed in the arterial borderzone or watershed areas, regions that are most Undetermined or other causes 15 (7.6) 1 (2.9) 0 (0)
Continuous variables were expressed as mean and SD. AF indicates atrial fibrillation; CMI, cerebral microinfarct; DM, diabetes mellitus; HT, hypertension; MTLA, medial temporal lobe atrophy; TIA, transient ischemic attack; TOAST, Trial of Org 10172 in Acute Stroke Treatment; VBR, ventricular-brain ratio; and WMH, white matter hyperintensities.
*CMIs (n=34) include both chronic and acute CMIs. †P value for comparison between patients without CMIs (n=197) and all patients with CMIs (n=34). ‡P value for comparison between patients without CMIs (n=197) and patients with chronic CMIs only (n=21). §Forty patients with TIA were not classified by TOAST classification.
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vulnerable to hypoperfusion. 21, 26 Cortical CMIs were also detected in animal models with chronic cerebral hypoperfusion. 26 In our study, however, watershed areas seemed not to be a preferential location for cortical CMIs. Interestingly, large-artery stenosis was also observed to be associated with the presence of CMIs in memory-clinic patients. 6 In short, CMIs are likely to have heterogeneous underlying causes. 6 Microembolism (eg, AF-related or artery-to-artery emboli) may be just one of these mechanisms. Small vessel disease (such as cerebral amyloid angiopathy and arteriosclerosis), large-artery atherosclerosis, hypoperfusion, and microembolism may all contribute and probably synergize in the formation of CMIs. In addition, we found that patients with repeated stroke/TIA had a higher frequency of CMIs, indicating that CMIs and ischemic stroke/TIA shared similar risk factors.
About the cognitive consequences of CMIs, we found that CMI preferentially impacted visuospatial functioning at baseline and longitudinally. Our finding is consistent with findings from a memory clinic-based study that observed a cross-sectional association between CMIs with a worse performance in visuoconstruction skills in addition to language. 27 The association with a decline in visuospatial functioning may be attributable to the frontal-parietal localization of cortical CMIs in the current study. 28, 29 This study has several strengths. First, CMIs were detected in vivo on 3.0T MRI, opening up a new window to better understand the pathophysiology, evolution, and clinical consequences of CMIs during life. Second, to the best of our knowledge, this is the first longitudinal report on the associations between CMIs and cognitive function. Third, we investigated a comprehensive list of clinical and neuroimaging data among a relatively large sample of subjects with stroke/ TIA. This study also has several limitations. First, only larger CMIs (≥1 mm) can be detected on MRI, underestimating the true burden of CMIs. However, before the availability of more advanced imaging techniques that can detect CMIs <1 mm, detection of CMIs on 3.0T MRI has still potential clinical relevance as shown in our study. Second, we used a relatively brief cognitive measure (MoCA) that is relatively crude when compared with detailed neuropsychological battery for delineating performance by cognitive domains. Therefore, the associations between CMI and cognitive domains reported here are considered as preliminary and should be examined in future studies utilizing detailed cognitive tests. Likewise, although we observed a longitudinal association between CMIs and visuospatial functions, we were unable to support this association with imaging evidence as MRI was not repeated at follow-up. The exact mechanisms underlying the impact of CMIs on cognitive domain performance should be further examined in future studies with repeated imaging. In addition, as mentioned in the methods, patients were selected from the larger STRIDE study sample (total 1062 patients) based on having a 3.0T MRI examination. Patients who did not undergo 3.0T MRI were older, less educated, had poorer cognition, and more frequently AF. Given these differences, the actual burden of CMIs in the larger STRIDE study sample might be higher than we observed in this study, which rendered the generalizability of our study findings to patients with stroke or TIA as a whole limited. 
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